Current Approaches to Treatment of Ocular Graft-Versus-Host Disease
Author:
- Cynthia I. TungCTCynthia I. Tung
- 1 January 2017
- journal article
- review article
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 57 (2) , 65-88
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Clinical Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCornea, 2012
- Allogeneic Serum Eye Drops for the Treatment of Dry Eye Patients with Chronic Graft-Versus-Host DiseaseJournal of Ocular Pharmacology and Therapeutics, 2012
- Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHDCornea, 2012
- Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHDBone Marrow Transplantation, 2011
- Treatment of Ocular Graft-Versus-Host Disease With Topical Cyclosporine 0.05%Cornea, 2010
- High-frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-daily RegimenCornea, 2009
- Evaluation of the Role of ProKera in the Management of Ocular Surface and Orbital DisordersEye & Contact Lens: Science & Clinical Practice, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Use of Fluid-Ventilated, Gas-Permeable Scleral Lens for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2007
- Ocular graft vs. host disease experience from MD Anderson Cancer Center: Newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHDTransplantation and Cellular Therapy, 2006